日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Quantitative benefit-risk analysis for prophylactic vaccines in the context of FDAs benefit-risk framework

在FDA的获益-风险框架下,对预防性疫苗进行定量获益-风险分析

Yang, Hong; Yogurtcu, Osman N; Nukala, Ujwani; Funk, Patrick R; Izurieta, Hector S; Forshee, Richard A

Limosilactobacillus reuteri promotes the expression and secretion of enteroendocrine- and enterocyte-derived hormones.

罗伊氏乳杆菌促进肠内分泌激素和肠细胞衍生激素的表达和分泌

Di Rienzi Sara C, Danhof Heather A, Forshee Micah D, Roberts Ari, Britton Robert A

Physiologically Based Pharmacokinetic Modeling and Simulation in Regulatory Review: US FDA CBER Experience and Perspectives

基于生理的药代动力学建模与模拟在监管审查中的应用:美国FDA CBER的经验与展望

Tegenge, Million A; Yogurtcu, Osman N; Belov, Artur A; Wang, Xiaofei; Forshee, Richard A

Differences in influenza testing and treatment in micropolitan versus metropolitan areas in the U.S. using medicare claims data from 2010 to 2016

利用2010年至2016年美国医疗保险索赔数据,分析美国小都市区和都市区流感检测和治疗的差异

Couture, Alexia; Dahlgren, F Scott; Izurieta, Hector S; Forshee, Richard A; Lu, Yun; Reed, Carrie

Effectiveness over time of a primary series of the original monovalent COVID-19 vaccines in adults in the United States

美国成年人接种最初单价新冠疫苗系列后的长期有效性

Layton, J Bradley; Lloyd, Patricia C; Peetluk, Lauren S; Jiao, Yixin; Djibo, Djeneba Audrey; Gruber, Joann F; Deng, Jie; Bui, Christine; Lo, An-Chi; Ogilvie, Rachel P; Parambi, Ron; Miller, Michael; Song, Jennifer; Weatherby, Lisa B; Cho, Sylvia; Wong, Hui Lee; Clarke, Tainya C; Hervol, Jessica Rose; Illei, Dóra; Bell, Elizabeth J; Yang, Grace Wenya; Seeger, John D; Wernecke, Michael; Richey, Morgan M; Forshee, Richard A; Anderson, Steven A; Chillarige, Yoganand; McMahill-Walraven, Cheryl N; Amend, Kandace L; Anthony, Mary S; Shoaibi, Azadeh

Risk of neurologic or immune-mediated adverse events after COVID-19 diagnosis in the United States

美国新冠肺炎诊断后发生神经系统或免疫介导不良事件的风险

Fisher, Shelby S; Lindaas, Arnstein; Muthuri, Stella G; Lloyd, Patricia C; Gruber, Joann F; Richey, Morgan M; Lyu, Hai; Cheng, Angela S; Kowarski, Lisa S; McKillop, Mollie M; Bui, Christine; Clarke, Tainya C; Beers, Jeffrey; Burrell, Timothy; Duenas, Pablo Freyria; Chen, Yangping; Sheng, Minya; Forshee, Richard A; Anderson, Steven A; Chillarige, Yoganand; Anthony, Mary S; Shoaibi, Azadeh; Layton, J Bradley

Lessons Learned From Characterizing Long COVID Among US Medicare Beneficiaries

从美国医疗保险受益人中长期新冠症状的特征分析中汲取的经验教训

Lu, Yun; Lindaas, Arnstein; Izurieta, Hector S; Cozen, Myrna; Menis, Mikhail; Shi, Xiangyu; Steele, Whitney R; Wernecke, Michael; Chillarige, Yoganand; Kelman, Jeffrey A; Forshee, Richard A

Stroke Risk After COVID-19 Bivalent Vaccination Among US Older Adults

美国老年人接种新冠二价疫苗后的中风风险

Lu, Yun; Matuska, Kathryn; Nadimpalli, Gita; Ma, Yuxin; Duma, Nathan; Zhang, Henry T; Chiang, Yiyun; Lyu, Hai; Chillarige, Yoganand; Kelman, Jeffrey A; Forshee, Richard A; Anderson, Steven A

Safety of Ancestral Monovalent BNT162b2, mRNA-1273, and NVX-CoV2373 COVID-19 Vaccines in US Children Aged 6 Months to 17 Years

美国6个月至17岁儿童接种祖先型单价BNT162b2、mRNA-1273和NVX-CoV2373新冠疫苗的安全性

Hu, Mao; Shoaibi, Azadeh; Feng, Yuhui; Lloyd, Patricia C; Wong, Hui Lee; Smith, Elizabeth R; Amend, Kandace L; Kline, Annemarie; Beachler, Daniel C; Gruber, Joann F; Mitra, Mahasweta; Seeger, John D; Harris, Charlalynn; Secora, Alex; Obidi, Joyce; Wang, Jing; Song, Jennifer; McMahill-Walraven, Cheryl N; Reich, Christian; McEvoy, Rowan; Do, Rose; Chillarige, Yoganand; Clifford, Robin; Cooper, Danielle D; Forshee, Richard A; Anderson, Steven A

Stroke After Influenza Vaccines in Older Adults in the US, 2016 to 2019

2016年至2019年美国老年人接种流感疫苗后发生中风的情况

Lu, Yun; Matuska, Kathryn; Ma, Yuxin; Laniyan, Layo; Chillarige, Yoganand; Anderson, Steven A; Forshee, Richard A